Kwetkat A, Leischker A, Endres A, Heppner H
Z Gerontol Geriatr. 2023; 56(8):679-687.
PMID: 38051357
DOI: 10.1007/s00391-023-02265-1.
Eberlein V, Ahrends M, Bayer L, Finkensieper J, Besecke J, Mansuroglu Y
Viruses. 2023; 15(9).
PMID: 37766253
PMC: 10535182.
DOI: 10.3390/v15091846.
Shin G, Kang D, Cheong H, Choi S
Vaccines (Basel). 2022; 10(6).
PMID: 35746540
PMC: 9228362.
DOI: 10.3390/vaccines10060932.
Boccalini S, Pariani E, Calabro G, de Waure C, Panatto D, Amicizia D
J Prev Med Hyg. 2021; 62(2 Suppl 1):E1-E118.
PMID: 34909481
PMC: 8639053.
DOI: 10.15167/2421-4248/jpmh2021.62.2s1.
Youssef D, Abou-Abbas L, Farhat S, Hassan H
Hum Resour Health. 2021; 19(1):131.
PMID: 34689762
PMC: 8542355.
DOI: 10.1186/s12960-021-00673-1.
Recommendations of the Italian society for infectious and tropical diseases (SIMIT) for adult vaccinations.
Andreoni M, Sticchi L, Nozza S, Sarmati L, Gori A, Tavio M
Hum Vaccin Immunother. 2021; 17(11):4265-4282.
PMID: 34524945
PMC: 8828129.
DOI: 10.1080/21645515.2021.1971473.
Progress of Plant Medicine Derived Extracts and Alkaloids on Modulating Viral Infections and Inflammation.
Ti H, Zhuang Z, Yu Q, Wang S
Drug Des Devel Ther. 2021; 15:1385-1408.
PMID: 33833499
PMC: 8020337.
DOI: 10.2147/DDDT.S299120.
Personal and social patterns predict influenza vaccination decision.
Shaham A, Chodick G, Shalev V, Yamin D
BMC Public Health. 2020; 20(1):222.
PMID: 32050948
PMC: 7017468.
DOI: 10.1186/s12889-020-8327-3.
Cost-effectiveness of adult vaccinations: A systematic review.
Leidner A, Murthy N, Chesson H, Biggerstaff M, Stoecker C, Harris A
Vaccine. 2018; 37(2):226-234.
PMID: 30527660
PMC: 6545890.
DOI: 10.1016/j.vaccine.2018.11.056.
[Influenza: special aspects in old age].
Kwetkat A, Leischker A, Heppner H
Z Gerontol Geriatr. 2018; 51(5):585-596.
PMID: 29951833
DOI: 10.1007/s00391-018-1418-4.
The Potential Role of Fc-Receptor Functions in the Development of a Universal Influenza Vaccine.
Jegaskanda S
Vaccines (Basel). 2018; 6(2).
PMID: 29772781
PMC: 6027188.
DOI: 10.3390/vaccines6020027.
Treatment with broadly neutralizing influenza antibodies reduces severity of secondary pneumococcal pneumonia in mice.
van Someren Greve F, van der Sluijs K, Tuip A, Schultz M, de Jong M, Juffermans N
J Med Virol. 2018; 90(9):1431-1437.
PMID: 29718555
PMC: 6055667.
DOI: 10.1002/jmv.25212.
Optimizing the impact of low-efficacy influenza vaccines.
Sah P, Medlock J, Fitzpatrick M, Singer B, Galvani A
Proc Natl Acad Sci U S A. 2018; 115(20):5151-5156.
PMID: 29712866
PMC: 5960327.
DOI: 10.1073/pnas.1802479115.
Role of the pharmacist in reducing healthcare costs: current insights.
Dalton K, Byrne S
Integr Pharm Res Pract. 2018; 6:37-46.
PMID: 29354549
PMC: 5774321.
DOI: 10.2147/IPRP.S108047.
[Vaccination in advanced age].
Heppner H, Leischker A, Wutzler P, Kwetkat A
Internist (Berl). 2017; 59(2):205-212.
PMID: 29230484
DOI: 10.1007/s00108-017-0358-1.
Economic benefits of sharing and redistributing influenza vaccines when shortages occurred.
Chen S
PLoS One. 2017; 12(10):e0186418.
PMID: 29040317
PMC: 5645113.
DOI: 10.1371/journal.pone.0186418.
Immunogenicity and Safety of Trivalent Split Influenza Vaccine in Healthy Korean Adults with Low Pre-Existing Antibody Levels: An Open Phase I Trial.
Kang K, Han S, Hong T, Jeon S, Paek J, Kang J
Yonsei Med J. 2016; 57(6):1354-60.
PMID: 27593862
PMC: 5011266.
DOI: 10.3349/ymj.2016.57.6.1354.
Evaluation of Antihemagglutinin and Antineuraminidase Antibodies as Correlates of Protection in an Influenza A/H1N1 Virus Healthy Human Challenge Model.
Memoli M, Shaw P, Han A, Czajkowski L, Reed S, Athota R
mBio. 2016; 7(2):e00417-16.
PMID: 27094330
PMC: 4959521.
DOI: 10.1128/mBio.00417-16.
Strategies for Early Vaccination During Novel Influenza Outbreaks.
Laskowski M, Xiao Y, Charland N, Moghadas S
Sci Rep. 2015; 5:18062.
PMID: 26658016
PMC: 4677284.
DOI: 10.1038/srep18062.
Small Wonders-The Use of Nanoparticles for Delivering Antigen.
Taki A, Smooker P
Vaccines (Basel). 2015; 3(3):638-61.
PMID: 26350599
PMC: 4586471.
DOI: 10.3390/vaccines3030638.